查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1433352

全球神經血栓切除術設備市場 2023-2030

Global Neurothrombectomy Devices Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030 年），全球神經血栓切除設備市場將以 7.3% 的CAGR成長。該市場的成長歸因於全球急性缺血性中風發病率的增加、不健康生活方式的增加以及人們對該疾病的認知不斷提高，這些都推動了市場的成長。根據世界中風組織 2022 年情況說明書，所有年齡層的缺血性中風盛行率為 7,630,803 人。每年每 10 萬人的粗率為 94.5，每年每 10 萬人的年齡調整率為 98.6。每年有超過 760 萬例新缺血性中風。在全球範圍內，超過 62.0% 的中風事件是缺血性中風。其中，每年超過11%的缺血性中風發生在15-49歲的人群中，超過58.0%的缺血性中風發生在70歲以下的人群中，45.0%的缺血性中風發生在男性中， 55.0% 的缺血性中風發生在男性。% 的缺血性中風發生在女性身上。此外，2022年11月，《老年人口統計：美國老化肖像》一文報道，有5,410萬成年人，即美國人口的16.3%是老年人，其中包括65歲或以上的老年人。預計到 2040 年，老年人口將增至 22.0%，到 2060 年將增至 25.0%。

區隔市場前景

全球神經血栓切除術設備市場根據產品和最終用戶進行區隔。根據產品，市場區隔為血栓回收裝置、抽吸裝置和血管圈套器。此外，根據最終用戶，市場分為醫院和急診診所。在最終用戶中，預計醫院區隔市場將在預測期內佔據最大的市場佔有率。該區隔市場的大部分佔有率歸功於較低的成本、較高的效率和可用性。

預計血栓回收設備區隔市場將在全球神經血栓切除設備市場中佔據相當大的佔有率

在這些產品中，凝塊檢索設備子區隔市場預計將在預測期內成長。此區隔市場的推動因素是 AIS 日益普及以及主要市場參與者推出的產品數量不斷增加。它主要用於清除腦動脈中的血栓。此外，由於中風發病率不斷上升，老年患者（55 歲至 65 歲）的血栓回收器使用量增加。因此，越來越多的針對性疾病病例正在推動區隔市場的成長。此外，FDA 批准數量的增加正在加速該區隔市場的成長。 2023 年 6 月，Innova Vascular, Inc. 的 Laguna Clot Retriever (TM) 系統和 Malibu Aspiration Catheter (TM) 系統獲得美國食品和藥物管理局 (FDA) 510(k) 批准，用於外周脈管系統。這兩種新設備統稱為拉古納血栓切除系統。

區域展望

全球神經血栓切除設備市場根據地理位置進一步區隔，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，亞太地區預計將在預測期內大幅成長。這是由於對神經血栓切除術設備的需求不斷成長、老年人口不斷增加、醫療保健支出不斷增加以及心血管疾病 (CVD) 和心臟相關疾病的發病率不斷增加。

北美地區全球神經血栓切除設備市場預計將以顯著的CAGR成長

預計在預測期內，北美將在神經血栓切除術設備市場中佔據顯著佔有率。推動北美市場發展的重要因素包括神經血栓切除設備技術的不斷進步、中風發病率的上升、老年人口的增加以及政府對監測設備的有利法規。根據美國人口普查局的數據，老年人口增加了5,090 萬，從1920 年的490 萬（占美國總人口的4.7%）增加到2020 年的5,580 萬（占美國總人口的16.8%）。2020 年，大約每6 人中就有1 人患有老年失智症。美國的年齡在 65 歲及以上。 1920 年，這一比例還不到二十分之一。此外，未來對神經血栓切除裝置和其他技術進步的需求可能會增加，以確保改善 CVD 預防和控制。根據美國心臟協會的數據，心血管疾病仍然是美國的首要死因，2020 年導致 928,741 人死亡。此外，心臟相關疾病數量的增加和技術進步正在進一步推動該地區的市場。 2020 年，在美國，冠狀動脈心臟病 (CHD) 是美國 CVD 死亡的主要原因 (41.2%)，其次是中風 (17.3%)。

市場參與者展望

服務全球神經血栓切除設備市場的主要公司包括 Acandis GmbH、Medtronic plc、Penumbra, Inc. 和 Stryker Corp. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023 年 7 月，總部位於加州洛斯阿圖斯的一家開發標靶聯合療法的臨床階段生物製藥公司 RenovoRx, Inc. 與總部位於澳洲雪梨的臨床階段免疫腫瘤公司 Imugene Ltd 達成策略合作協議。研究合作旨在最佳化Imugene 溶瘤病毒療法與RenovoRx 經動脈微灌注(TAMP) 治療平台的交付，以治療難以接近的腫瘤。作為合作的一部分，Imugene 和 RenovoRx 將研究利用 RenovoRx 的 TAMP 治療平台管理 Imugene 的 CF33 溶瘤病毒技術的能力。

報告涵蓋：

  • 2022年市場價​​值資料分析及2030年預測。
  • 每個區隔市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球神經血栓切除術設備市場的主要公司。根據現有資料，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵區隔市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 依區隔
    • 依地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Acandis GmbH
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Medtronic plc
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Penumbra, Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Stryker Corp.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場區隔

  • 全球神經血栓切除術設備市場（依產品）
    • 血塊回收裝置
    • 抽吸裝置
    • 血管圈套器
  • 全球神經血栓切除術設備市場（依最終用戶）
    • 醫院
    • 急診診所

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Abbott Laboratories
  • Acandis GmbH
  • ARGON MEDICAL
  • Boston Scientific Corp.,
  • Edwards Lifesciences Corp.,
  • INARI Medical
  • Johnson & Johnson Pvt Ltd
  • Koninklijke Philips N.V.
  • Microport Scientific Corp.,
  • Penumbra, Inc.
  • Phenox GmbH
  • Siemens Healthineers
  • Teleflex Inc.,
  • Terumo Corp.,
  • Vesalio, LLC
  • W.L. Gore & Associatess, Inc.
Product Code: OMR2028016

Global Neurothrombectomy Devices Market Size, Share & Trends Analysis Report by Product (Clot Retrievers Devices, Aspiration Devices, and Vascular Snares), and by End-User (Hospitals and Emergency Clinics), Forecast Period (2023-2030)

The global neurothrombectomy devices market is anticipated to grow at a CAGR of 7.3% during the forecast period (2023-2030). The growth of this market is attributed to the increasing incidences of acute ischemic stroke globally, rising adoption of unhealthy lifestyles and increasing awareness of the disorder among the population is fueling market growth. According to the World Stroke Organization Fact Sheet 2022, Prevalence for all Ischemic stroke for all ages were 7,630,803. The crude rate per 100,000 per year was 94.5, and Age-adjusted rate per 100,000, per year was 98.6. There are over 7.6 million new ischemic strokes each year. Globally, over 62.0% of all incident strokes are ischemic strokes. Of which, each year, over 11% of all ischemic strokes occur in people 15-49 years of age, over 58.0% of all ischemic strokes occur in people aged under 70 years, 45.0% of all ischemic strokes occur in men, and 55.0% of all ischemic strokes occur in women. In addition, in November 2022, the article "Senior Population Statistics: A Portrait of Aging Americans", reported 54.1 million adults or 16.3% of the US population are seniors including aged 65 or older. The senior population is expected to rise to 22.0% by 2040 and 25.0% by 2060.

Segmental Outlook

The global neurothrombectomy devices market is segmented based on product and end-user. Based on the product, the market is sub-segmented into clot retrievers devices, aspiration devices, and vascular snares. Further, based on end-user, the market is bifurcated into hospitals and emergency clinics. Among the end-user, the hospitals sub-segment is anticipated to hold the largest market share during the forecast period. The large share of this segment is credited to the lower costs, higher efficiency, and availability.

The Clot Retrievers Devices Sub-Segment is Anticipated to Hold a Considerable Share of the Global Neurothrombectomy Devices Market

Among the products, clot retrievers devices sub-segments expected to grow over the forecast period. The segment is driven by the owing to rising prevalence of AIS and an increasing number of product launches by key market players. It is majorly used for removing blood clots from the cerebral arteries. Furthermore, the use of clot retrievers has increased in elderly patients (aged 55 to 65) owing to growing incidence of stroke. Hence, growing cases of targeted disorder are driving segment growth. In addition, the growing number of FDA approvals is accelerating the segmental growth. In June 2023, Innova Vascular, Inc. received US Food and Drug Administration (FDA) 510(k) clearance for its Laguna Clot Retriever™ System and its Malibu Aspiration Catheter™ System for use in the peripheral vasculature. The two new devices are collectively known as the Laguna Thrombectomy System.

Regional Outlook

The global neurothrombectomy devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, the Asia-Pacific region is anticipated to grow considerably over the forecast period. This is owing to the growing demand for neurothrombectomy devices, increasing geriatric population, the rising healthcare expenditure, and increasing incidences of cardiovascular diseases (CVDs) and heart related conditions.

The North America Region is Expected to Grow at a Significant CAGR in the Global Neurothrombectomy Devices Market

North America is expected to hold a prominent share in the neurothrombectomy devices market during the forecast period. The significant factors fueling the North America market including growing technological advancements in neurothrombectomy devices, rising incidences of strokes, increasing geriatric population, and favorable government regulations regarding monitoring devices. According to the United States Census Bureau, the older population increased by 50.9 million, from 4.9 million (or 4.7% of the total US population) in 1920 to 55.8 million (16.8%) in 2020. In 2020, about 1 in 6 people in the US were age 65 and over. In 1920, this proportion was less than 1 in 20. In addition, the demand for neurothrombectomy devices, and other technological advancements to ensure improved CVD prevention and control is likely to rise in the future. According to the American Heart Association, CVDs remains as the leading cause of death in the US, accounted for 928,741 deaths in the year 2020. Additionally, the increasing number of heart-related disorders and technological advancements are further driving the market in the region. In 2020 in the US, coronary heart disease (CHD) was the leading cause (41.2%) of deaths attributable to CVD in the US, followed by stroke (17.3%).

Market Players Outlook

The major companies serving the global neurothrombectomy devices market includes Acandis GmbH, Medtronic plc, Penumbra, Inc., and Stryker Corp., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2023, RenovoRx, Inc., a Los Altos, California-based clinical-stage biopharmaceutical company developing targeted combination therapies, and Imugene Ltd, a clinical-stage immuno-oncology company headquartered in Sydney, Australia, entered a strategic research collaboration to optimize the delivery of Imugene's oncolytic virus therapy with RenovoRx's trans arterial micro perfusion (TAMP) therapy platform for the treatment of difficult-to-access tumors. As part of the collaboration, Imugene and RenovoRx will investigate the ability to administer Imugene's CF33 oncolytic virus technology with RenovoRx's TAMP therapy platform.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global neurothrombectomy devices market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Acandis GmbH
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Medtronic plc
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Penumbra, Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Stryker Corp.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Neurothrombectomy Devices Market by Product
    • 4.1.1. Clot Retrievers Devices
    • 4.1.2. Aspiration Devices
    • 4.1.3. Vascular Snares
  • 4.2. Global Neurothrombectomy Devices Market by End-User
    • 4.2.1. Hospitals
    • 4.2.2. Emergency Clinics

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Abbott Laboratories
  • 6.2. Acandis GmbH
  • 6.3. ARGON MEDICAL
  • 6.4. Boston Scientific Corp.,
  • 6.5. Edwards Lifesciences Corp.,
  • 6.6. INARI Medical
  • 6.7. Johnson & Johnson Pvt Ltd
  • 6.8. Koninklijke Philips N.V.
  • 6.9. Microport Scientific Corp.,
  • 6.10. Penumbra, Inc.
  • 6.11. Phenox GmbH
  • 6.12. Siemens Healthineers
  • 6.13. Teleflex Inc.,
  • 6.14. Terumo Corp.,
  • 6.15. Vesalio, LLC
  • 6.16. W.L. Gore & Associatess, Inc.

LIST OF TABLES

  • 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 2. GLOBAL CLOT RETRIEVERS NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL ASPIRATION NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL VASCULAR SNARES NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 6. GLOBAL NEUROTHROMBECTOMY DEVICES FOR HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL NEUROTHROMBECTOMY DEVICES FOR EMERGENCY CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 9. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 12. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 13. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 14. EUROPEAN NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 15. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 16. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 17. ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER,2022-2030 ($ MILLION)
  • 18. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE BY PRODUCT, 2022 VS 2030 (%)
  • 2. GLOBAL CLOT RETRIEVERS NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL ASPIRATION NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL VASCULAR SNARES NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 5. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 6. GLOBAL NEUROTHROMBECTOMY DEVICES FOR HOSPITALS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL NEUROTHROMBECTOMY DEVICES FOR EMERGENCY CLINICS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL NEUROTHROMBECTOMY DEVICES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. US NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 10. CANADA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. UK NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. FRANCE NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. GERMANY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. ITALY NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. SPAIN NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. REST OF EUROPE NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. INDIA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. CHINA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. JAPAN NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. SOUTH KOREA NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. REST OF ASIA-PACIFIC NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF THE WORLD NEUROTHROMBECTOMY DEVICES MARKET SIZE, 2022-2030 ($ MILLION)